fda d.i.s.c.o. burst edition: fda approval of tafinlar (dabrafenib) in combination with mekinist ...
Published 5 months ago • 21 plays • Length 5:01Download video MP4
Download video MP3
Similar videos
-
4:01
fda d.i.s.c.o. burst edition: fda approval of tafinlar (dabrafenib) with mekinist (trametinib) fo...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) in combination with lenvim...
-
3:30
fda d.i.s.c.o. burst edition: fda approval of lenvima (lenvatinib) in combination with keytruda (...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) for patients with metastat...
-
5:21
clinical robustness of csf ptau/aβ42 ratio for alzheimer’s disease diagnosis
-
9:53
recent fda approvals for multiple myeloma and what to expect from treatments in development
-
4:12
extractables & leachables: overview
-
3:01
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) in combination with trastu...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) as adjuvant treatment for ...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of padcev (enfortumab vedotin-ejfv) with keytruda (pem...
-
3:31
fda d.i.s.c.o. burst edition: fda approval of keytruda (pembrolizumab) for the adjuvant treatment...
-
3:01
fda d.i.s.c.o. burst: approval of pepaxto (melphalan flufenamide) in combination with dexamethaso...
-
5:01
fda d.i.s.c.o. burst edition: fda approvals of tivdak (tisotumab vedotin-tftv) for recurrent or m...
-
5:31
fda d.i.s.c.o. burst edition: fda approvals of trodelvy (sacituzumab govitecan) for locally advan...
-
8:01
fda d.i.s.c.o.: fda approval of cablivi for acquired thrombotic thrombocytopenic purpura
-
7:01
fda d.i.s.c.o. burst edition: fda approvals of tabrecta (capmatinib) for metastatic non-small cel...
-
6:31
fda d.i.s.c.o. burst edition: fda approvals of tukysa (tucatinib) with trastuzumab for colorectal...
-
6:01
fda d.i.s.c.o. burst edition: fda approvals of imbruvica (ibrutinib) for pediatric patients with ...
-
1:08
fda approval of adjuvant dabrafenib/trametinib in braf melanoma
-
4:37
tafinlar® (dabrafenib) mekinist® (trametinib) mechanism of action for advanced melanoma
-
0:30
dr. postow on fda approval of adjuvant dabrafenib plus trametinib in braf-mutant melanoma